Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Trial Assessing the Effect of Pembrolizumab Combined with Radiotherapy in Patients with Relapsed, Refractory, Specified Stages of Cutaneous T-cell Lymphoma (CTCL) Mycosis Fungoides (MF)/Sezary Syndrome (SS)Disease Attributes, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Sezary syndrome, T-cell non-Hodgkin lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, mycosis fungoides, neoplasm, primary cutaneous T-cell non-Hodgkin lymphomaActive, not recruitingPhase 22024-12-09NCT03385226

2 results · Page 1 of 1

Swipe the table sideways for more columns.

11 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Beatson West of Scotland Cancer CentreGlasgowUnited Kingdom18
Churchill HospitalOxfordUnited Kingdom17
Clatterbridge Cancer CentreMetropolitan Borough of WirralUnited Kingdom10
Freeman HospitalNewcastleUnited Kingdom14
Guy's & St Thomas'LondonUnited Kingdom1
Nottingham City HospitalNottinghamUnited Kingdom19
Southampton University HospitalSouthamptonUnited Kingdom4
The ChristieManchesterUnited Kingdom7
University Hospital BirminghamBirminghamUnited Kingdom2
University Hospital CoventryCoventryUnited Kingdom8
Velindre Cancer CentreCardiffUnited Kingdom12